老年冠心病患者血清胆红素和超敏C反应蛋白水平的变化分析(3)
参见附件(12kb)。
[8] SCHWERTHER H A, JACKSON W G, TOLAN G.Association of low serum concentration of bilirubin with increased risk of coronary artery disease[J]. Clin Chem,1994,40(1):18-23.
[9] TROUGHTON J A, WOODSIDE J V, YOUNG I S, et al. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction(PRIME)[J]. Eur J Cardiovasc Prev Rehabil, 2007, 14(1):79-84.
[10] LLINGER R, BILBAN M, ERAT A, et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation[J]. Circulation, 2005, 112(7):1030-1039.
[11] VITEK L, SCHWERTNER H A. The heme catabolic pathway and its protective effects on oxidative stress mediated diseases[J]. Adv Clin Chem, 2007,43:1-57.
[12] 杨俊娟,程宇刚,张钧华.胆红素和氧自由基与心血管疾病的关系[J]. 中国动脉硬化杂志,2006,14(8):728-730.
[13] BASIGLIO C L, ARRIAGA S M, PELUSA F, et al. Complement activation and disease: protective effects of hyperbilirubinaemia[J]. Clin Sci(Lond), 2009,118(2):99-113.
[14] FERNANDES A, BRITES D. Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents[J]. Curr Pharm Des, 2009,15(25):2915-2926.
[15] 刘娟,任洁,陈丽琴.超敏C反应蛋白与急性冠脉综合征的关系[J]. 现代医学,2009,37(1):14-15.
[16] ISHIKAWA J, TAMURA Y, HOSHIDE S, et al. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1[J]. Stroke, 2007,38(3):911-917.
[8] SCHWERTHER H A, JACKSON W G, TOLAN G.Association of low serum concentration of bilirubin with increased risk of coronary artery disease[J]. Clin Chem,1994,40(1):18-23.
[9] TROUGHTON J A, WOODSIDE J V, YOUNG I S, et al. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction(PRIME)[J]. Eur J Cardiovasc Prev Rehabil, 2007, 14(1):79-84.
[10] LLINGER R, BILBAN M, ERAT A, et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation[J]. Circulation, 2005, 112(7):1030-1039.
[11] VITEK L, SCHWERTNER H A. The heme catabolic pathway and its protective effects on oxidative stress mediated diseases[J]. Adv Clin Chem, 2007,43:1-57.
[12] 杨俊娟,程宇刚,张钧华.胆红素和氧自由基与心血管疾病的关系[J]. 中国动脉硬化杂志,2006,14(8):728-730.
[13] BASIGLIO C L, ARRIAGA S M, PELUSA F, et al. Complement activation and disease: protective effects of hyperbilirubinaemia[J]. Clin Sci(Lond), 2009,118(2):99-113.
[14] FERNANDES A, BRITES D. Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents[J]. Curr Pharm Des, 2009,15(25):2915-2926.
[15] 刘娟,任洁,陈丽琴.超敏C反应蛋白与急性冠脉综合征的关系[J]. 现代医学,2009,37(1):14-15.
[16] ISHIKAWA J, TAMURA Y, HOSHIDE S, et al. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1[J]. Stroke, 2007,38(3):911-917.
您现在查看是摘要介绍页,详见PDF附件(12kb)。